...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Expectations for the AGM?
Reply New Message
Prev Message Back To Forum Threaded View Next Message

I'm sure Don is trying his best to get deals.  He's in his 60s I think so I suspect he'd like to cash out of both Zenith and RVX, the sooner the better.  I'm not expecting anything much to come from the Zenith AGM.  I'm afraid I'll start yawning if I hear anything that's excessively, inordinately, unrealistically optimistic.

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply